Health Catalyst Inc

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Health Catalyst Inc reports solid 2022 performance and eyes margin growth opportunities

Health Catalyst Inc delivered strong financial performance in 2022, with revenue growth, improved EBITDA, and a positive outlook for 2023. The company's focus on client relationships, tech-enabled services, and margin improvement positions it well for future success. Challenges such as long sales cycles and migration costs are being managed strategically to drive growth.

Health Catalyst beats Q1 revenue targets, eyes tech-enabled growth

Health Catalyst's Q1 2023 performance showed revenue growth and operational efficiency, with a focus on recurring revenue and client relationships.
While facing challenges in the health system market and revenue lumpiness, the company aims for growth through tech-enabled services and cost-saving strategies.
Opportunities lie in expanding into the ambulatory space, offering modular solutions, and investing in tech capabilities for long-term differentiation and client value.
Overall, Health Catalyst remains cautious about expansion, prioritizing being a differentiated long-term partner to effectively deliver for clients.

Health Catalyst beats Q2 expectations, eyes growth in managed services

Health Catalyst's Q2 performance exceeded expectations, with raised guidance for 2023.
Focus on tech-enabled managed services and long-term client relationships driving growth.
Challenges include longer sales cycles and improving gross margins in contracts.
Opportunities lie in margin improvement, summit impact on bookings, and clinic operations.

Health Catalyst Inc beats Q3 revenue, eyes strong Q4 bookings

Health Catalyst Inc (HCAT) exceeded revenue expectations in Q3 2023 and raised full-year guidance, with strong bookings performance.
The company is focusing on optimizing costs, anticipating a large bookings quarter in Q4 2023.
Recognized for team member engagement and client success stories, with a healthy cash position.
Anticipating growth opportunities in professional services and tech-enabled managed services contracts.

Health Catalyst exceeds Q4 revenue targets, eyes sustainable growth

Health Catalyst Inc's Q4 2023 earnings call highlighted strong financial performance, exceeding revenue and EBITDA guidance, with a focus on client growth and retention.
The company's strategic objectives include migrating clients to a next-gen data platform, balancing growth between tech and services, and driving profitability through operational efficiency.
While facing challenges in client migration and balancing growth, Health Catalyst is well-positioned to capitalize on opportunities like the next-gen platform rollout and cross-selling efforts.
Overall, Health Catalyst's performance, strengths, challenges, and opportunities indicate a strategic focus on sustainable growth, profitability, and enhancing client relationships.

Health Catalyst surpasses Q1 expectations, eyes tech-driven growth

Health Catalyst demonstrated financial resilience and client-centric approach in Q1 2024.
Strategic focus on technology and services to drive growth and avoid limitations.
Opportunities in adjacent markets and client engagement for sustained expansion.
Challenges include managing R&D expenses and potential disruptions from external factors.

Health Catalyst surpasses Q2 revenue targets, eyes growth opportunities

Health Catalyst's Q2 2024 performance exceeded expectations, showcasing strong revenue and margin metrics.
The company's strategic strengths lie in client recognition, acquisitions, platform migration progress, and growth outlook.
Challenges include client retention, revenue growth, margin optimization, and disciplined capital deployment.
Opportunities for Health Catalyst include leveraging financial strength, cross-selling, technology focus, and Ignite platform benefits.

Health Catalyst exceeds Q3 expectations, eyes growth through strategic initiatives

Health Catalyst Inc's Q3 2024 earnings call showcased strong financial performance, positive outlook, and strategic initiatives for growth.
The company's focus on client relationships, market demand, and acquisitions positions it well for future success and industry leadership.
While challenges like margin expansion and competition exist, Health Catalyst Inc's strengths and opportunities indicate a promising trajectory.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

The consensus price target hints at a 29% upside potential for Health Catalyst (HCAT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Wall Street Analysts Believe Health Catalyst (HCAT) Could Rally 28.97%: Here's is How to Trade

SALT LAKE CITY , Jan. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a multi-year partnership with SacValley MedShare (SacValley), one of California's largest and most established qualified health information organization (QHIO). Together with its regional partners, SacValley works to improve the quality and safety of healthcare by sharing health information securely and efficiently between all providers, facilities, and patients.

SacValley MedShare Selects Health Catalyst to Power its Qualified Health Information Organization (QHIO)

SALT LAKE CITY , Nov. 29, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, announced WakeMed Health & Hospitals ("WakeMed") has achieved $10M variable cost reduction by decreasing unnecessary care variation while helping to improve care quality. Unwarranted clinical variations are inconsistencies in care practices that can sometimes negatively affect patient outcomes and organizational performance and are a main driver of excess costs in healthcare.

Health Catalyst's Analytics Solutions Save WakeMed Health & Hospitals $10 Million, Accelerates Clinical Transformation

Health Catalyst, Inc. (NASDAQ:HCAT ) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET Company Participants Adam Brown - Senior Vice President of FP&A & Investor Relations Dan Burton - Chief Executive Officer Bryan Hunt - Chief Financial Officer Conference Call Participants Vishal Patel - Piper Sandler Daniel Grosslight - Citi Sameer Patel - Evercore ISI Jenny Shen - BTIG Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo Sarah James - Cantor Fitzgerald Operator Welcome to the Health Catalyst Third Quarter 2023 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode, and the floor will be open for your questions following the presentation.

Health Catalyst, Inc. (HCAT) Q3 2023 Earnings Call Transcript

BOSTON--(BUSINESS WIRE)--Electronic Registry Systems (ERS) acquired by Health Catalyst; Outcome Capital served as the exclusive strategic and financial advisor to ERS.

Outcome Capital Announces Electronic Registry Systems (ERS) Acquisition by Health Catalyst

The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Compared to Estimates, Health Catalyst (HCAT) Q3 Earnings: A Look at Key Metrics

SALT LAKE CITY, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2023.

Health Catalyst Reports Third Quarter 2023 Results

SALT LAKE CITY , Nov. 2, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a comprehensive, multi-year strategic partnership with Accountable Health Partners (AHP), a clinically integrated network (CIN) with a proven record of improving quality outcomes and delivering value to 400,000 patients in the Greater Rochester area. The clinically integrated network has nearly 3,000 physician and advanced practice providers and twelve of the region's leading hospitals.

Accountable Health Partners, A Clinically Integrated Network, Signs Multi-Year Partnership with Health Catalyst to Advance Operational Improvements

SALT LAKE CITY , Nov. 2, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that it has acquired Electronic Registry Systems, Inc. (ERS), a market leader in cancer registry software and services. Headquartered in Cincinnati, Ohio, ERS provides cancer registry compliance and informatics services to enable customers to achieve their cancer center clinical and business objectives with a goal of improving cancer care for every patient.

Health Catalyst Acquires ERS, Bolsters Tech-Enabled Managed Services Offering with Data Abstraction and Oncology Registry Management Capabilities

SALT LAKE CITY , Oct. 27, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported preliminary financial results for the quarter ended September 30, 2023. Given recent market and sector dynamics, we are reporting our preliminary financial results and providing fourth quarter and updated full year 2023 guidance in advance of the date of our release of our full third quarter 2023 operating results.

Health Catalyst Reports Third Quarter 2023 Preliminary Results

SALT LAKE CITY, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its third quarter 2023 operating results on Wednesday, November 8, 2023, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Health Catalyst to Announce Third Quarter 2023 Operating Results and Host Conference Call on Wednesday, November 8, 2023

Health Catalyst (HCAT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

All You Need to Know About Health Catalyst (HCAT) Rating Upgrade to Strong Buy

SALT LAKE CITY , Sept. 27, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that two technologies, Health Catalyst Pop Analyzer™ and Health Catalyst Care Flow™, have achieved National Committee for Quality Assurance (NCQA) Prevalidation for Population Health Management in 2023.

Health Catalyst Pop Analyzer™ and Health Catalyst Care Flow™ Achieve NCQA Population Health Management Prevalidation Status

Health Catalyst, Inc. provides a healthcare data platform for healthcare service providers. The company has shown promising growth in its tech-enabled managed services offering. However, Health Catalyst still has substantial operating losses and has not made significant progress towards operating breakeven.

Health Catalyst Sees Growth In Tech-Enabled Managed Services

SALT LAKE CITY , Sept. 5, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Health Catalyst was recognized in the latest Gartner Hype Cycle for Healthcare Providers, 2023 (July 2023); Hype Cycle for Healthcare Data, Analytics and AI, 2023 (July 2023); Hype Cycle for Digital Care Delivery Including Virtual Care, 2023 (July 2023); Hype Cycle for Real-Time Health System Technologies, 2023 (July 2023) and Hype Cycle for U.S. Healthcare Payers, 2023 (July 2023).

Health Catalyst Recognized in Five Gartner® Hype Cycle™ Reports

Health Catalyst, Inc. (NASDAQ:HCAT ) Q2 2023 Earnings Conference Call August 8, 2023 5:00 PM ET Company Participants Adam Brown - SVP Finance & IR Dan Burton - CEO Bryan Hunt - CFO Conference Call Participants Samir Patel - Evercore ISI Vishal Patel - Piper Sandler Daniel Grosslight - Citi David Larsen - BTIG Jack Wallace - Guggenheim Securities Scott Schoenhaus - Keybanc Capital Richard Close - Canaccord Genuity Sarah James - Cantor Fitzgerald Operator Welcome to the Health Catalyst Second Quarter 2023 Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Adam Brown, Senior Vice President of FP&A and Investor Relations.

Health Catalyst, Inc. (HCAT) Q2 2023 Earnings Call Transcript

The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Health Catalyst (HCAT) Reports Q2 Earnings: What Key Metrics Have to Say

Health Catalyst (HCAT) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to loss of $0.03 per share a year ago.

Health Catalyst (HCAT) Q2 Earnings and Revenues Surpass Estimates

SALT LAKE CITY , Aug. 8, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has been Great Place To Work® Certified™ in India . This award recognizes the excellent culture Health Catalyst team members in India have built.

Health Catalyst Is Great Place To Work® Certified™ in India

SALT LAKE CITY, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2023.

Health Catalyst Reports Second Quarter 2023 Results

SALT LAKE CITY , July 28, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Twistle® by Health Catalyst (Twistle), a leading clinical workflow and patient engagement platform, has met certain key regulatory, security and privacy requirements necessary for earning HITRUST certification. HITRUST leverages nationally and internationally accepted standards including ISO, NIST, PCI, HIPAA, and others to ensure a comprehensive set of baseline security controls.

Twistle by Health Catalyst Achieves HITRUST CSF® Certification

SALT LAKE CITY, July 24, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2023 operating results on Tuesday, August 8, 2023, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Health Catalyst to Announce Second Quarter 2023 Operating Results and Host Conference Call on Tuesday, August 8, 2023

Despite a challenging macro environment, HCAT continues to show strong fundamentals, with growth driven by strategies such as targeting existing customers for up/cross-selling and expanding pipeline opportunities. The company is also looking to leverage AI technology to improve efficiency, speed, and cost, which could lead to a higher margin profile and more cash savings for reinvestment. I believe that successful execution of the new strategy and macroeconomic recovery could lead to a stock rerating.

Health Catalyst: Share Price Still Not Reflective Of Intrinsic Value

SALT LAKE CITY , June 27, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq:  HCAT ), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expanded partnership with the Ohio Health Information Partnership (The Partnership) who operates CliniSync, a nonprofit Health Information Exchange that facilitates the sharing of patient records between providers, hospitals, and health systems throughout Ohio. The Partnership has selected KPI Ninja by Health Catalyst™, a comprehensive, end-to-end interoperability platform built for Health Information Exchanges (HIE), to enhance data exchange at scale in a rapid, real-time process.

Ohio Health Information Partnership Powers CliniSync with Health Catalyst

Health Catalyst, Inc. (NASDAQ:HCAT ) Q1 2023 Earnings Conference Call May 9, 2023 5:00 PM ET Company Participants Adam Brown - Senior Vice President, Finance and Investor Relations Dan Burton - Chief Executive Officer Bryan Hunt - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Jared Haase - William Blair Jessica Tassan - Piper Sandler Elizabeth Anderson - Evercore ISI Anna Kruszenski - SVB Securities Richard Close - Canaccord Genuity Daniel Grosslight - Citi John Ransom - Raymond James Thomas Kelliher - RBC Capital Markets David Larsen - BTIG Jack Wallace - Guggenheim Securities Scott Schoenhaus - Keybanc Capital Operator Welcome to the Health Catalyst First Quarter 2023 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation.

News for Health Catalyst Inc Stock (HCAT)